Topoisomerase II α Gene alteration in Triple Negative Breast Cancer and Its Predictive Role for Anthracycline-Based Chemotherapy (Egyptian NCI Patients)

OBJECTIVE: Triple negative breast cancer is an aggressive variant of breast cancer; it forms about 15% of breast cancer cases. It lacks the responsiveness to hormonal and targeted therapies. Anthracyclines remain the treatment option for these patients. Anthracyclines are cardiotoxic, so predicting...

Descripción completa

Detalles Bibliográficos
Autores principales: Eltohamy, Mahitab Ibrahim, Badawy, Omnia Mohammed, kinaai, Naglaa El, Loay, Iman, Nassar, Hanan Ramadan, Allam, Rasha Mahmoud, Sakr, Mona Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428522/
https://www.ncbi.nlm.nih.gov/pubmed/30583686
http://dx.doi.org/10.31557/APJCP.2018.19.12.3581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428522/
https://www.ncbi.nlm.nih.gov/pubmed/30583686
http://dx.doi.org/10.31557/APJCP.2018.19.12.3581

Ejemplares similares